With Enbrel patent victory, Amgen scores major win against biosims—and Sandoz takes a big loss

[anonymous]

So Sheila Carol and Alex

What’s the common theme here? Someone in the greater clinical acceptance doesn’t support Sandoz NVS or you are just absolutely horrible at your job responsibilities.

https://www.fiercepharma.com/pharma...nbrel-dodging-biosim-competition-to-4-8b-drug

 

[anonymous]

Oh come on. We still might get the blockbuster peg filgrastim

And we are killing it with our phone app for opioid addiction. Killing it!

We have given away so many trinkets and gift cards to those who use it.

WE ARE ONE HECK OF A SANDOZ

 

[anonymous]

But - let’s make an agreement to manufacture an API that competes with a product from Amgen that we co-promote such that we can keep things interesting.

 

[anonymous]

Yea sandoz is about to be dissolved. BioPharma failure majorly

 

[anonymous]

My oncology customers laugh at me. They say every time I see you sandoz has bad news in the press. What’s up with you guys?

 

[anonymous]

If Sandoz were asked to make generic saltines I think they would botch that up

 

[anonymous]

Oh boy peg filgrastim. Oh boy oh boy. Contract play.

When’s your big late to market peg coming?

Oh then you have the epi pen. Oh boy oh boy. Nothing that would keep Field more employed but you got it. Two buy ins a year.

You go sandoz. Stand proud. Stand like a woman. You are one super duper sandoz

 

[anonymous]

The only people still present here at sandoz onc are ones that can’t get hired any where else or neee their time of service to hit a vested mark.

There is absolutely no work being done at all!